Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1228 ARTÍCULOS , VIENDO DEL 1201 AL 1215

Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases

Van der Schyf CJ.

Drug Dev Res. 2016 Dec;77(8):458-468. doi: 10.1002/ddr.21368. Epub 2016 Nov 4.

The Role of Mitochondrial Aldehyde Dehydrogenase 2 (ALDH2) in Neuropathology and Neurodegeneration

Chen CH, Joshi AU, Mochly-Rosen D.

Acta Neurol Taiwan. 2016 Dec 15;25(4)(4):111-123.

Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis

Lyoo CH, Cho H, Choi JY, Hwang MS, Hong SK, Kim YJ, Ryu YH, Lee MS.

J Alzheimers Dis. 2016;51(3):671-5. doi: 10.3233/JAD-151052.

Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics

Belaidi AA, Bush AI.

J Neurochem. 2016 Oct;139 Suppl 1:179-197. doi: 10.1111/jnc.13425. Epub 2016 Feb 10.

The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease

Gadhave K, Bolshette N, Ahire A, Pardeshi R, Thakur K, Trandafir C, Istrate A, Ahmed S, Lahkar M, Muresanu DF, Balea M.

J Cell Mol Med. 2016 Jul;20(7):1392-407. doi: 10.1111/jcmm.12817. Epub 2016 Mar 29.

Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases

Forloni G, Artuso V, La Vitola P, Balducci C.

Mov Disord. 2016 Jun;31(6):771-81. doi: 10.1002/mds.26624. Epub 2016 Mar 31.

The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease

Clark LF, Kodadek T.

ACS Chem Neurosci. 2016 May 18;7(5):520-7. doi: 10.1021/acschemneuro.6b00042. Epub 2016 Apr 14.

Palmitoylation in Alzheimer's disease and other neurodegenerative diseases

Cho E, Park M.

Pharmacol Res. 2016 Sep;111:133-151. doi: 10.1016/j.phrs.2016.06.008. Epub 2016 Jun 9.

Endocannabinoid System in Neurological Disorders

Ranieri R, Laezza C, Bifulco M, Marasco D, Malfitano AM.

Recent Pat CNS Drug Discov. 2016;10(2):90-112. doi: 10.2174/1574889810999160719105433.

Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function

Leighton PL, Allison WT.

J Alzheimers Dis. 2016 Jul 6;54(1):3-29. doi: 10.3233/JAD-160361.

[A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy]

Pupyshev AB, Korolenko TA, Tikhonova MA.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2016 Sep;66(5):515-540.

Evaluating Recall and Recognition Memory Using the Montreal Cognitive Assessment: Applicability for Alzheimer's and Huntington's Diseases

Van Liew C, Santoro MS, Goldstein J, Gluhm S, Gilbert PE, Corey-Bloom J.

Am J Alzheimers Dis Other Demen. 2016 Dec;31(8):658-663. doi: 10.1177/1533317516668573. Epub 2016 Sep 26.

AMPK in Neurodegenerative Diseases

Domise M, Vingtdeux V.

Exp Suppl. 2016;107:153-177. doi: 10.1007/978-3-319-43589-3_7.

The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review

Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD.

Oxid Med Cell Longev. 2016;2016:8590578. doi: 10.1155/2016/8590578. Epub 2016 Dec 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias